5 December 2017Europe

Horizon Discovery expands CRISPR licence with ERS Genomics

UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

Europe

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

Europe

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.